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Global gene regulation during 
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Miriam F. Moffatt1
Immunoglobulin class switch recombination (CSR) to IgE is a tightly regulated process central to 
atopic disease. To profile the B-cell transcriptional responses underlying the activation of the germinal 
centre activities leading to the generation of IgE, naïve human B-cells were stimulated with IL-4 and 
anti-CD40. Gene expression and alternative splicing were profiled over 12 days using the Affymetrix 
Human Exon 1.0 ST Array. A total of 1,399 genes, forming 13 temporal profiles were differentially 
expressed. CCL22 and CCL17 were dramatically induced but followed a temporal trajectory distinct from 
classical mediators of isotype switching. AICDA, NFIL3, IRF4, XBP1 and BATF3 shared a profile with 
several genes involved in innate immunity, but with no recognised role in CSR. A transcription factor 
BHLHE40 was identified at the core of this profile. B-cell activation was also accompanied by variation 
in exon retention affecting >200 genes including CCL17. The data indicate a circadian component and 
central roles for the Th2 chemokines CCL22 and CCL17 in the activation of CSR.
IgE levels are under tight regulatory control, with IgE possessing the shortest half-life and being the least abun-
dantly expressed of all immunoglobulin isotypes1. IgE underlies type I hypersensitivity and raised IgE levels are 
seen in increasingly prevalent atopic diseases including asthma, atopic dermatitis and allergic rhinitis. Antibody 
isotype is determined by the constant region genes of the heavy Ig chain locus (CH), which confer distinct effec-
tor properties to the immunoglobulin such as Fc receptor specificity, complement activation, stability, ability 
to transcytose and thereby also tissue distribution. IgE is produced when B cells are stimulated to undergo 
Immunoglobulin class switch recombination (CSR) in response to antigen stimulation and co-stimulatory sig-
nals, replacing the constant region genes at the heavy chain locus (initially Cμ and Cδ ) with those encoding IgE 
(Cε ). For a B cell to successfully undergo CSR, a number of cellular processes including, proliferation, control 
of apoptosis, DNA recombination and cell differentiation must be coordinated. These processes usually occur in 
the germinal centres of secondary lymphoid organs or local tissues following antigen encounter in the presence 
of T cell help. While the core mechanisms of the germinal centre activities leading to IgE are well established, the 
fine-scale transcriptional machinery underlying the production and dynamic regulation of IgE remains relatively 
unknown2 despite its clinical relevance.
In this study, we have simultaneously monitored the changes in gene expression both in terms of coarse-scale 
gene abundance and fine-scale exon retention that accompany the activation and progression of class switching 
in human B cells. Naïve B cells were stimulated in vitro with IL-4 and anti-CD40 signals that mimic the T cell 
help received in the germinal centre, inducing a strong activation of NF-kB leading to a proliferative burst and 
CSR to IgE and IgG3. This co-stimulation signal was therefore applied here to provide a controlled window on the 
molecular pathways that regulate these germinal centre processes underlying IgE production in human B cells4.
Results
Temporal variation in and patterns of global gene expression during activation of CSR. At a 
5% false discovery rate (FDR) a total 1,399 genes (transcript clusters, TCs) attained significance for differential 
expression in one or more of the assayed time windows (Figure S1). Consistent with known biology5,6 these 
differentially expressed genes were most significantly enriched for biological process terms relating to cell cycle 
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(GO:0007049, P-value 1.50E-27, Fold Enrichment 2.26) and localisation within the chromosome cellular com-
ponent (GO:0005694, P-value 5.51E-20, fold enrichment 2.46). The most enriched molecular function was ATP 
binding (GO:0005524, P-value 1.54E-09, fold enrichment 1.55).
The most significant differential expression, with an adjusted P-value of 4.39E-07, was attained at TC 3662687, 
the potent Th2 and regulatory T-cell attracting chemokine gene, CCL22. CCL22 and CCL17 are both ligands 
for the chemokine receptor CCR47 and all three of these targets fall within the top twenty genes differentially 
expressed during the activation of immunoglobulin class switching in human activated B cells (Table 1, Fig. 1). 
CCL22 and CCL17 were potently induced during the early phase of activation, with a substantial 63.95 fold 
increase for CCL22 during the first 12 hours, and 18.33 fold increase for CCL17 during the same period. Both 
CCL22 and CCL17 are NF-kappa B (NF-kB) target genes, highlighting a central role for the NF-kB pathway in the 
activation of CSR. The top differentially expressed genes also contained another NF-kB target gene the TNF recep-
tor associated factor (TRAF1)8, as well as the cytokine receptor IL17RB which mediates the activation of NF-kB.
Other less well characterised differentially expressed genes include the non-enzymatic replication factor 
MCM10 (TC 3235789), kinesin family member 14 (KIF14), part of a proliferation signature seen during early 
B-cell development9 (TC 2450345), and a protein regulator of cytokinesis (PRC1) (TC 3639031, Table 1). PRC1 is 
a known associative protein of KIF1410, acting together to promote cell division, and all three of these genes have 
Transcript 
cluster F P-Value Adj.P.Val Chromosome Gene assignment
3662687 97.57 3.94E-11 4.39E-07 chr16 CCL22
2624565 80.50 1.64E-10 9.16E-07 chr3 IL17RB
3662710 76.11 2.49E-10 9.24E-07 chr16 CCL17
3214451 65.55 7.45E-10 2.08E-06 chr9 NFIL3
2450345 63.20 9.74E-10 2.17E-06 chr1 KIF14
3235789 56.97 2.07E-09 3.33E-06 chr10 MCM10
3639031 56.90 2.09E-09 3.33E-06 chr15 PRC1
3223738 55.01 2.68E-09 3.47E-06 chr9 TRAF1
2899102 54.66 2.80E-09 3.47E-06 chr6 —
3776139 51.59 4.25E-09 4.56E-06 chr18 NDC80
2364438 50.73 4.81E-09 4.56E-06 chr1 NUF2
3636391 50.09 5.26E-09 4.56E-06 chr15 HOMER2/LOC100131860/HOMER2P1
2616131 50.02 5.32E-09 4.56E-06 chr3 CCR4/SEC13P1
2838656 49.26 5.94E-09 4.72E-06 chr5 HMMR
2417528 48.72 6.42E-09 4.77E-06 chr1 DEPDC1
3910785 48.01 7.14E-09 4.89E-06 chr20 AURKA/AURKAPS1/RAB3GAP2
3587457 47.72 7.46E-09 4.89E-06 chr15 ARHGAP11B/ARHGAP11A/LOC100288637
2946232 45.73 1.01E-08 6.27E-06 chr6 HIST1H1C
2792166 44.96 1.14E-08 6.49E-06 chr4 MARCH1
Table 1.  The top 20 differentially expressed TC across the 288-hour time course.
Figure 1. Expression of CCR4 and its ligands CCL22, and CCL17 during the activation of CSR. Abundance 
is displayed on a log2 scale. Results of triplicates are shown. Time point is in hours. Abbreviations: Transcript 
Cluster (TC).
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reported mutations and/or clinically significant variation in abundance in various cancers11,12. These cytokinesis 
and proliferation related transcriptional changes may have implications for the efficiency of class switching, as 
well as the regulation of isotype class13,14.
Next the complexity of variation in transcription amongst the 1,399 genes differentially expressed during the 
activation of CSR was reduced to 13 central temporal transcription profiles using fuzzy c-means clustering (Fig. 2 
Figure 2. Temporal expression patterns exposed by soft clustering of differentially expressed genes. Soft 
clusters of genes differentially expressed during activation of CSR. Genes are colour-coded according to their 
cluster membership values. Genes exhibiting the highest membership values are shown in red. Pattern class 
(A) quasi-on/off; Pattern class (B) graduated induction; Pattern class (C) Transient induction; Pattern class (D) 
Transient down regulation.
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and S2, Table 2). This unsupervised classification technique clusters genes that exhibit temporal coordination 
and reveals cluster cores; tightly co-expressed genes potentially under shared regulatory control. Genes possess-
ing highly correlated expression profiles are more likely to be bound by a common transcription factors15. As 
such, clusters were assessed for an over-representation of individual Transcription Factor Binding Sites (TFBS) 
amongst members, demonstrating significant enrichment in 3 clusters (Table 2). Clusters could also be at least 
partially differentiated by biological process through patterns of enrichment for gene ontology terms (Table 2). 
Inspection of the identified clusters revealed on/off phenomena (Clusters A1 and A2), as well as groups of genes 
showing graduated sustained induction (Clusters B1 and B2), transient induction (Clusters C1–C6) and transient 
down-regulation (Clusters D1–D3).
Five genes with well-established roles in class switching and germinal centre cell function were found to clus-
ter together in a single temporal profile representing genes that are rapidly activated during the stimulation time 
course, cluster B1, containing 126 members (Fig. 3). Cluster B1 contained the lymphocyte specific transcription 
factor interferon regulatory factor 4 (IRF4)16, the DNA deaminase AICDA encoding AID17, the transcriptional 
activator and regulator of the unfolded protein response XBP1, the CSR-related transcription factor BATF318,19, 
and the B-cell intrinsic transcriptional regulator (NFIL3) that was recently identified as a key regulator of IgE 
class switching in mice20. All five genes were highly differentially expressed during the activation time course 
(Fig. 4; IRF4, TC 2891341, F = 10.68, P = 3.37E10-03; AICDA, TC 3443206, F = 40.21, P = 9.40E10-06; XBP1, 
TC 3956589, F = 29.25, P = 3.22E10-05; BATF3, TC 2454818, F = 33.99, P = 1.84E-05; NFIL3, transcript cluster 
3214451, F = 65.55, P = 2.08E-06).
Fine-scale structure within cluster B1 was revealed by complete linkage hierarchical clustering (Fig. 4), indi-
cating that AICDA’s closest neighbours are C11orf91 (TC 3368707); NFIL3 (TC 3214451) a key regulator of IgE 
production, airway hyper-responsiveness and effector T-cell responses21,22; and IL17RB (TC 2624565), a central 
component of NF-kB activation.
Other members of temporal cluster B1 included several genes previously implicated in innate immune func-
tion through allelic association. These include Lymphotoxin alpha, LTA (TC 2902407), variants of which have 
been associated with asthma23; the innate immune receptor NOD2 (TC 3660175) which has been associated 
with several atopy related traits24,25 and the negative regulator of lipopolysaccharide (LPS) signalling SOCS1 (TC 
3680213), variants of which have been associated with total serum IgE26. The impact these allelic variants have on 
CSR efficiency, B cell differentiation and IgE production may be an area worthy of future exploration.
Cluster B1 showed a rapid and strong induction at 12 hours with continued increments in abundance up to 
120 hours after which it plateaued. The cluster was significantly enriched for motifs binding the transcription 
factors RSRFC4 (P-value 9.32E-03) and STAT (P-value 1.71E-02). The gene statistically most central to, or rep-
resentative of cluster B1 was the transcription factor BHLHE40. BHLHE40 is a primary target of the vitamin 
D receptor27, regulated by environmental signals and conferring downstream effects on the cell cycle, cellular 
differentiation and the mammalian molecular clock28. Vitamin D deficiency is a growing area of interest in the 
development and modulation of asthma and allergies29. Given the presence of several known regulators of B-cell 
germinal centre function in cluster B1, cluster membership and within-cluster proximity may provide a useful 
metric for prioritising differentially expressed genes for further analysis.
Cluster
# 
Members Core genes (Gene ID, Membership)
GO Biological Process enrichment 
(Benjamini P-value)
TFBS enrichment 
(Benjamini P-value)
A1 153 CCL22 (3662687, 0.97), CCL17 (3662710, 0.96) NS BACH1 (6.29E-03), BACH2 (2.80E-02)
A2 83 TMEM2 (3209384, 0.99), TRIB2 (2470165, 0.99) GO:0002376~immune system process (2.35E-03) NS
B1 126 BHLHE40 (2608725, 0.95), AARS (3697015, 0.92) GO:0044106~cellular amine metabolic process (2.01E-02)
RSRFC4 (1.86E-02), 
STAT (1.71E-02)
B2 112 ZNF581 (3842301, 0.95), GAS6 (3502829, 0.92) NS NS
C1 79 MRTO4 (2323559, 0.98), CLUH (3741171, 0.97) GO:0022613~ribonucleoprotein complex biogenesis (2.78E-04) NS
C2 112 GNL3 (2624074, 0.96), ATP5B (3458033, 0.96) NS NS
C3 105 DTL (2378937, 0.96), CLSPN (2406420, 0.93) GO:0006259~DNA metabolic process (2.79E-47) NS
C4 151 BUB1B (3589697, 0.98), KIF2C (2334098, 0.98) GO:0000279~M phase (2.94E-52) NFY (1.39E-05)
C5 99 PGRMC1 (3988740, 0.94), VAT1L (3669552, 0.86) GO:0022403~cell cycle phase (1.12E-03) NS
C6 128 HMGCL (2401609, 0.93), FLOT1 (2948587, 0.89) NS NS
D1 69 OAS1 (3432438, 0.98), CBLB (2687255, 0.96) NS NS
D2 69 JMJD7 (3590709, 0.93), CALCOCO1 (3456353, 0.91) NS NS
D3 113 LRIF1 (2427688, 0.94), APOBEC3H (3945684, 0.92) NS NS
Sum 1399
Table 2.  Temporal cluster summary. TFBS significant at a 5% threshold are shown. Where more than one GO 
term achieves significance at this threshold, the term accompanied by the lowest Benjamini P-value is shown. 
The two genes exhibiting the highest membership values for a given cluster are reported. Abbreviations: Not 
Significant (NS), Transcription Factor Binding Site (TFBS), Gene Ontology (GO), Biological Process (BP).
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Similar to cluster B1, cluster A1 (153 members) demonstrated a potent early induction at 12 hours but rapidly 
stabilised after this time point, resembling an ‘on-switch’ phenomenon. Central to this cluster, and exhibiting the 
highest membership values, were CCL22 and CCL17 (0.97 and 0.96 respectively); two of the top three genes most 
Figure 3. Expression of five key CSR genes over the 288 hour time course following IL-4 and anti-CD40 
stimulation. Abundance is displayed on a log2 scale. Results of triplicates are shown. Time point is in hours. 
Abbreviations: Transcript Cluster (TC).
Figure 4. Fine-scale substructure within temporal transcription cluster B1. Figure 4 is a circulized 
dendrogram of temporal transcription cluster B1. Branches are coloured according to their groupings using a 
cut height of 4. Colour density at the branch terminal nodes reflects the significance of differential expression, 
with the smallest P-values yielding the darkest nodes. For ease of interpretation only the first Affymetrix gene 
annotation is shown. Five genes with well-established roles in class switching and germinal centre cell function 
are highlighted in red text.
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differentially expressed during B-cell activation in this data set (Table 1). Coordination of these hub genes and 
separation from well-established regulators of germinal centre function (distributed in B1) suggest that CCL22 
and CCL17 may represent a temporally separable early stage component of B-cell activation and preparation for 
CSR. Cluster A1 notably also contained NFKB1 and NFKB2, encoding the NF-kB precursors p100 and p105, 
which together form higher order complexes to regulate the NF-kB signalling system30. Consistent with a hypoth-
esis of shared regulatory control, cluster A1 was significantly enriched for transcription factor binding sites for 
Bach1 and Bach2 (P-values 6.29E-03 and 2.80E-02 respectively). Bach1 and Bach2 both promote B-cell develop-
ment31 whilst Bach2 is also known to be critical for both CSR and somatic hyper-mutation32.
Physical co-localisation of differentially expressed genes. Amongst the 1,399 differentially expressed 
TCs there were 78 physically co-localised groups, where co-localisation was defined as physical co-occurrence 
within 5 Kb. The size of these groups ranged between 2 and 6 TCs, with the majority (70 groups) containing 2 TCs, 
6 groups containing 3, 1 group containing 4 and 1 group containing 6. The latter group (containing annotated 
members HIST1H1A, HIST1H3A, HIST1H4A, HIST1H4B, HIST1H3B and HIST1H2AB) physically localised to 
histone gene cluster 1 (HIST1) on chromosome 6p22-p21 with all members belonging to temporal co-expression 
cluster C4 indicating co-ordinated transcription. Histones are the major protein constituent of chromatin around 
which eukaryotic DNA is wound. H1, H2A, H3 and H4 are all replication-dependent histones, such that tran-
scription is tightly linked to cell cycle phase, allowing packaging of newly replicated DNA. A second physically 
co-localised group of replication-dependent histones mapped to histone gene cluster 2 (HIST2) on chromosome 
1q21 (3 member group: HIST2H2BF, HIST2H2BE and HIST2H2AB). A further 3 member co-localisation group 
on chromosome 11q12-q13.1 mapped to the evolutionarily conserved fatty acid desaturase (FADS) gene cluster, 
including poly-unsaturated fatty acid processing enzymes FADS1 and FADS2 and extending to the nearby flap 
structure-specific endonuclease 1 (FEN1). FADS1 and FADS2 have a head-to-head (H2H) orientation and control 
blood levels of polyunsaturated fatty acids (PUFA). Genes with a H2H orientation are prone to co-expression and 
co-functionality33. Disturbed expression of the FADS genes has previously been reported in several IgE-mediated 
diseases, including asthma34 and atopic dermatitis35,36, but this is the first such association with the direct cellular 
processes leading to IgE production. Variation in FADS gene expression during the activation time course is 
shown in supplementary Figure S3.
Temporal changes in exon retention during B-cell activation. In order to catalogue variation in 
exon usage during B-cell activation via CD40 and IL-4 we examined the same longitudinal data set at the level of 
the exon (probeset) using Limma’s diffSplice function37. This method does not rely on existing gene annotations 
and therefore enables the detection of novel as well as established splice events. Differential exon splicing was 
non-uniformly distributed across the 288 hours following co-stimulation. An immediate early peak in exon splic-
ing was seen in the 0–12 hour time point; 154 genes, of which only 79 (51.3%) attained significance for differential 
gene expression. A lesser peak was seen in the 120–288 hour time window; 50 genes, of which 29 (58.0%) attained 
significance for differential gene expression. Only a small number of genes achieved significance for differential 
splicing in the intervening periods (12–36 hours N = 3; 36–72 hours N = 12; and 72–120 hours N = 2). A list of the 
genes exhibiting the most significant variation in exon usage during the activation time course is given in Table 3.
In total just 110 (7.86%) of genes that met criteria for differential expression also achieved significance for dif-
ferential splicing. Likewise, nearly half (49.31%) of differentially spliced genes showed no significant evidence of 
differential expression. These results demonstrate that the data gained through exon and transcript level expres-
sion profiling are incompletely overlapping and as such may offer complementary insights.
Patterns were sought amongst differentially spliced genes by testing for enrichment of gene ontology (GO) 
terms. At an adjusted P-value threshold of 0.05, significant enrichment was seen in the immediate early phase 
(0–12 hours, 5 terms), and the late phase (120–288 hour, 47 terms) only (Table S1). Genes demonstrating early 
changes to gene structure were most significantly enriched for molecular function terms relating to signalling and 
receptor function, including GO:0004871~signal transducer activity (P-value 4.27E-05, fold enrichment 2.30), 
GO:0060089~molecular transducer activity (P-value 4.27E-05, fold enrichment 2.30) and GO:0004872~receptor 
activity (P-value 6.00E-05, fold enrichment 2.58). Conversely, the most significantly enriched GO terms 
in genes showing late phase differences in exon retention related to cellular localisation in the kinetochore 
(GO:0000776, P-value 5.43E-05, fold enrichment 27.57) and assembly related biological processes including 
GO:0006334~nucleosome assembly (P-value 5.66E-05, fold enrichment 32.62) and GO:0031497~chromatin 
assembly (P-value 6.74E-05, fold enrichment 30.94).
The gene XBP1 (TC 3956589), which has a well-established role in plasma cell differentiation, is known to 
undergo a splice reaction to generate its active form38,39. Here we observe a significant change in XBP1 exon 
usage between 0 and 12-hours (FDR 5.30E-04), affecting probeset (exon) 3956608, which is relatively depleted 
(Figure S4). Among genes exhibiting the most significant variation in exon retention during the B-cell activa-
tion, we identified CCL17 (FDR 2.33E-10), a hub in activation-related transcriptional cluster A1 outlined above. 
Two CCL17 probesets showed differential usage between 0 and 12 hours: probeset 3662711, which was depleted 
relative to other exons, and probeset 3662716, which was relatively enriched (Fig. 5). Current Netaffx annota-
tions place these probesets at exon 1 and exon 4 of CCL17 respectively. Other top hits included the Semaphorin 
SEMA4C (FDR 5.97E-07, TC 2565592) with known effects on myogenic differentiation and emerging evidence 
of a role in B cell immune response40, and the protein phosphatase 1 inhibitor PPP1R14A (FDR 8.35E-07, TC 
3861272) a gene capable of binding NF-kB and implicated in the control of airway hyper-responsiveness41.
Stability of exon splicing reactions. Amongst differentially spliced genes, only 4 showed significant var-
iation in 2 temporal windows. For 3 of these genes (hedgehog acyltransferase [HHAT, TC 2378369, probeset 
2378431], chromatin licensing and DNA replication factor 1 [CDT1, TC 3673684, probeset 3673705] and the 
www.nature.com/scientificreports/
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NDC80 kinetochore complex component SPC24 [TC 3850660, probeset 3850667]) the same exon was affected 
in both windows, with opposite directions of effect relative to the remainder of the gene, suggesting a short-lived 
temporary change to exon structure in these genes. The remainder of differentially spliced genes achieved signif-
icance in only one time window, indicating that the majority of activation-related changes in exon retention are 
persistent, at least within the bounds of the time frame tested.
The outer kinetochore NDC80 complex consists of 4 proteins encoded by the genes NDC80, NUF2, SPC24 and 
SPC25. As well as differential splicing of SPC24 described above, all four genes met criteria for overall differential 
expression (Figure S5). The NDC80 complex is required for kinetochore assembly and chromosome congression, 
and participates in spindle checkpoint signalling42. These roles are vital to metaphase–anaphase transition during 
mitosis, and highlight a role in cell cycle control.
Discussion
Immunoglobulin class switching occurs in mature B cells in response to antigen stimulation and co-stimulatory 
signals received from T helper cells. A limited number of B cell specific components have been identified as 
contributing to this process, notably AID encoded by the gene AICDA43, which initiates and is essential for not 
only CSR but also the related diversification event, somatic hypermutation44. Although class switching is essential 
for the expression of a different immunoglobulin isotype, it is not the only process required. Activated B cells 
undergo a coordinated program of proliferation, DNA recombination and mutation, rescue from apoptosis and 
cell differentiation in order to become antibody secreting plasma cells. Most insights into the mechanics of this 
process have been acquired through mice expressing reporter proteins or mice possessing a targeted genetic 
modification. Here we sought to explore the dynamic transcriptional processes underlying the germinal centre 
activities that accompany class switching to IgE and IgG through global exon profiling of a primary human B-cell 
TC P Value FDR Chr Gene Assignment Time Window
2316605 9.13E-19 7.43E-15 1 PLCH2 TP.12 hr-TP.0 hr
3735847 4.77E-16 2.59E-12 17 SEPT9 TP.12 hr-TP.0 hr
3662710 5.73E-14 2.33E-10 16 CCL17 TP.12 hr-TP.0 hr
3368940 9.91E-13 3.23E-09 11 ABTB2 TP.12 hr-TP.0 hr
3740432 2.64E-10 5.97E-07 17 SCARF1 TP.12 hr-TP.0 hr
2565592 2.79E-10 5.97E-07 2 SEMA4C TP.12 hr-TP.0 hr
2739714 2.93E-10 5.97E-07 4 C4orf32 TP.12 hr-TP.0 hr
3861272 4.62E-10 8.35E-07 19 PPP1R14A TP.12 hr-TP.0 hr
3818515 7.89E-10 1.22E-06 19 TRIP10 TP.12 hr-TP.0 hr
3866094 8.26E-10 1.22E-06 19 PTGIR TP.12 hr-TP.0 hr
3850660 1.10E-08 1.79E-04 19 SPC24 TP.36 hr-TP.12 hr
3957873 2.41E-07 1.96E-03 22 EIF4ENIF1 TP.36 hr-TP.12 hr
3204692 2.91E-06 1.58E-02 9 ARHGEF39 TP.36 hr-TP.12 hr
3585905 2.22E-06 1.21E-02 15 APBA2 TP.72 hr-TP.36 hr
3852407 5.92E-06 1.91E-02 19 RFX1 TP.72 hr-TP.36 hr
2327391 8.19E-06 1.91E-02 1 SESN2 TP.72 hr-TP.36 hr
3590014 8.23E-06 1.91E-02 15 CASC5 TP.72 hr-TP.36 hr
2887490 1.33E-05 2.71E-02 5 STC2 TP.72 hr-TP.36 hr
3838254 1.62E-05 2.89E-02 19 PPFIA3 TP.72 hr-TP.36 hr
2895792 1.78E-05 2.89E-02 6 RNF182 TP.72 hr-TP.36 hr
2827772 2.69E-05 3.98E-02 5 ADAMTS19 TP.72 hr-TP.36 hr
3184896 1.75E-06 1.73E-02 9 ZNF483 TP.120 hr-TP.72 hr
3514348 2.13E-06 1.73E-02 13 GUCY1B2 TP.120 hr-TP.72 hr
3538403 6.88E-09 5.33E-05 14 LRRC9 TP.288 hr-TP.120 hr
3850660 9.82E-09 5.33E-05 19 SPC24 TP.288 hr-TP.120 hr
3673684 3.96E-08 1.61E-04 16 CDT1 TP.288 hr-TP.120 hr
2946369 6.89E-08 1.94E-04 6 — TP.288 hr-TP.120 hr
2635184 7.14E-08 1.94E-04 3 HHLA2 TP.288 hr-TP.120 hr
3565663 2.92E-07 5.06E-04 14 DLGAP5 TP.288 hr-TP.120 hr
2334098 3.11E-07 5.06E-04 1 KIF2C TP.288 hr-TP.120 hr
3296512 1.01E-06 1.50E-03 10 POLR3A TP.288 hr-TP.120 hr
3903146 1.68E-06 1.96E-03 20 E2F1 TP.288 hr-TP.120 hr
3248289 2.57E-06 2.78E-03 10 CDK1 TP.288 hr-TP.120 hr
Table 3.  Uniquely annotated genes showing the most significant evidence of differential splicing at a 5% 
FDR. For ease of interpretation TC accompanied by more than one gene annotation are not shown. Results are 
limited to the top ten TC exceeding an FDR of 0.05, per time window. Abbreviations: Chromosome (Chr), Time 
Point (TP), Hours (hr), False Discovery Rate (FDR), Transcript Cluster (TC).
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time series following activation mimicking a Th2 mediated response. The data generated identify a host of novel 
CSR components that are known to individually regulate CSR, cell differentiation, proliferation and survival, and 
shed light on the temporal patterning and co-ordination between existing GC associated genes. Defining these 
genes’ roles in the activation of B cells leading to IgE production will not only help to understand the wider mech-
anisms of class switching, but may also provide insights into defective IgE responses and allergic pathogenesis.
We observed a complex transcriptional cascade composed of 1,399 genes during B-cell activation, organised at 
a fundamental level into 13 quantitative transcriptional profiles or trajectories. We confirmed involvement of sev-
eral key germinal centre response genes including AICDA, IRF4, XBP1, BATF3 and NFIL3, and showed that these 
well-established regulators of CSR exhibit synchronic, co-ordinated expression, forming a single 126 gene cluster, 
with BHLHE40; an environmentally inducible moderator of circadian rhythms and cellular differentiation, at 
its core. Consistent with BHLHE40’s status as a hub gene, BHLHE40 was recently shown to operate as a master 
regulator of germinal centre activities, modulating the expression of > 100 target genes45. Circadian oscillations 
in symptom severity are a prominent feature of atopic diseases including atopic dermatitis, asthma, chronic urti-
caria and allergic rhinitis46–48. Moreover, time-of-day related variation in IgE/mast cell allergic reactions was 
recently demonstrated to depend on the circadian clock in mice49, with such reactions pharmacologically inhib-
ited through experimental adjustment of the molecular clock50. Mice deficient for the BHLHE40 ortholog dis-
play a variety of immune features including abnormal IgG1 and IgE levels and defective elimination of activated 
B-cells, as well as exhibiting circadian rhythm phenomena51. Like BHLHE40, NFIL3 also participates in signalling 
pathways relating to the circadian clock52 and together these data suggest there may be a circadian component to 
class switch recombination and that this may be of relevance to time-of-day phenomena in IgE driven diseases.
During the early stages of B cell activation the most pronounced changes in gene transcription affected the 
genes encoding the chemokines CCL22 and CCL17 and the cytokine receptor IL17RB. CCL22 in particular 
showed a greater than 60-fold increase during the first 12 hours of activation. CCL22 and CCL17 are positioned at 
the very core of a single B-cell transcriptional profile, enriched for motifs targeting the Bach family of transcrip-
tion factors, and temporally separable from the well-established GC related genes described above. IL17RB on the 
other hand, shows highly synchronic expression with AICDA, possessing one of the most proximal expression 
profiles of all genes examined. Clinically, both CCL22 and CCL17 have been suggested as biomarkers for dis-
ease activity in atopic dermatitis (AD), and raised cord blood (CB) levels of CCL22 predict subsequent allergic 
sensitisation, whilst raised CB CCL17 predicts the later development of allergic symptoms, including asthma53. 
Consistent with these observations, allergen exposure in sensitised individuals leads to a dynamic increase in 
CCL17 and CCL2254; an effect that can be inhibited in vitro through CCR4 blockade55. The secretion of CCL22 
and CCL17 by B cells is well known to recruit Th2 cells (via CCR4) and as such is central to the germinal center 
response56. Similarly, CCR4 expression has previously been detected in non-germinal center B cells57. To our 
knowledge the importance of B cell expressed CCR4 in the human germinal center response has however not 
previously been investigated. These findings have important clinical implications given that high affinity neutra-
ligands have been developed for CCL22 and CCL17, and these inhibit both the chemokine-induced intracellular 
calcium responses and CCR4 endocytosis in vitro, and inflammation in vivo in a murine model of asthma58. Of 
relevance to atopic dermatitis, the synthetic molecule 5,6-dihydroergosteol-glucoside (DHE-Glc) has also been 
shown to suppress TNF-α /IFN-γ -induced expression of CCL17 and CCL22 in the human keratinocyte cell line 
HaCaT, and attenuate levels of CCL22, CCL17 and IgE in a mouse model of atopic dermatitis as well as improve 
skin inflammatory symptoms59.
IL17RB abundance has previously been shown to increase upon allergen challenge in patients with seasonal 
allergic rhinitis60, and to correlate with IgE abundance in asthmatics, accounting for as much as 12% of its var-
iance61. The data presented here further support the association and show that the increase in IL17RB forms 
an early component of the transcriptional cascade that initiates and the germinal centre response in B cells. 
Consistent with this observation, mice lacking the murine homolog of IL17RB show reduced levels of IgE62 and 
are resistant to IgE-mediated experimental food allergy63.
In addition to temporal clustering, B-cell activation-related genes showed evidence of physical clustering. 
The largest group included 6 TCs in evolutionarily conserved histone cluster 1, including a member of the H1 
family, HIST1H1A. Histone H1 has previously been shown to influence mast cell-mediated type I hyperreac-
tivity in mice64. Other physically co-localised groups included the fatty acid desaturase (FADS) gene cluster on 
chromosome 11q12. Here we showed that FADS1 and 2 are induced early during the activation process. Altered 
expression of FADS genes has been documented in asthma and atopic dermatitis, and FADS gene cluster variants 
are suggested to modulate the effect of dietary intake on allergic disease65.
As well as gross changes in transcript abundance we have observed activation induced changes in exon usage, 
predominantly occurring early in the germinal centre response and sustained thereafter. Only three genes showed 
transient changes in exon usage, HHAT, CDT1 and SPC24. The cell cycle regulatory protein CDT1 controls the 
initiation of DNA replication through its interactions with Geminin, and shows rapid recruitment to sites of DNA 
damage in human cells66; suggesting a potential contribution to CSR at the point of DNA double-strand break 
initiation and repair. SPC24 forms part of the NDC80 kinetochore complex. This complex is encoded by 4 genes, 
all of which were differentially expressed during activation. Several NDC80 components have been implicated in 
cancer prognosis, with overexpression exerting a positive impact on cellular proliferation, an effect that is at least 
partially reversible through experimental knockdown67,68. A host of other genes with known alternative tran-
scripts showed differential exon usage during the culture time course, and future functional distinction between 
these isoforms may yield novel insights into B-cell germinal centre biology.
Finally, the data presented reveal involvement of various innate immunity candidate genes, associated with 
diseases such as asthma and atopic dermatitis, in the fundamental mechanisms of B-cell activation and class 
switch recombination. A group of these genes including NOD2, SOCS1 and LTA show synchronic expression 
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with key components of CSR and germinal centre activity such as AICDA and NFIL3. Further exploration of 
these patterns may provide novel insights into the molecular mechanism underlying their involvement in disease.
In summary, we present a complex transcriptional cascade occurring following activation of germinal centre 
activities in primary human tonsillar B-cells. We acknowledge that these transcriptional phenomena may be subject 
to variation relating to the location of B-cell activation and the prevailing microenvironment. Nevertheless, these 
data provide a solid foundation upon which future investigations may build. We show that CCL22, CCL17 and 
IL17RB play central roles in the early stages of B-cell activation, and that CCL22 and CCL17 exhibit a quantitative 
profile distinct from several established mediators of the germinal centre response. We additionally demonstrate 
that B-cell activation coincides with systematic variation in exon usage, affecting a spectrum of targets, including 
notably CCL17. Understanding these genes’ contribution to germinal centre activities will not only bring new 
insights of the mechanisms of class switching but may also provide novel opportunities for therapeutic intervention.
Methods
The study was approved by the ethics committee of Guy’s Hospital, London and was performed in accordance 
with the approved guidelines and regulations.
Naive B cells isolation. Human B cells were isolated from the tonsils of three patients undergoing routine 
tonsillectomies at the Evelina Children’s Hospital. All donors were recruited in accordance with the guidelines 
imposed by Guy’s Hospital Research Ethics Committee (study No. 08 H0804 94) and informed consent was 
obtained before inclusion in the study. All research protocols were approved (following review) by Guy’s and St. 
Thomas’ Foundation Trust Research and Development Dept. (Study No. RJ1 09/0325). The patients were all aged 
between 2 and 14 years, had no history of asthma or any known allergies or long standing medical conditions 
(except tonsillitis) and were not taking any medications. The patients’ parents or legal guardians gave informed 
written consent for participation in this study. Total B cells were isolated from the tonsil as previously described69. 
Naïve B cells were subsequently separated by FACSorting (FACSAria™ , BD Biosciences), Naïve B cells being 
IgD+, CD38Low, CD27−. B cell purity was assessed by flow cytometry using fluorescently-labelled antibodies 
(Dako Cytomation) and a FACSCalibur™ flow cytometer (BD Biosciences)4.
Cell culture. B cells were cultured in 24-well plates (Nunc) at 0.5 × 106 cells/mL in RPMI medium (Invitrogen 
Ltd.), supplemented with transferrin (35 μ g/mL, Sigma-Aldrich Company Ltd.), insulin (5 μ g/mL, Sigma-Aldrich 
Company Ltd.), penicillin (100 IU/mL), streptomycin (100 μ g/mL), glutamine (2 mM) (all Invitrogen Ltd.) and 10% 
foetal bovine serum (FBS) (Hyclone, Perbio Biosciences Ltd.). To stimulate CSR to IgE, media was supplemented 
with 1 μ g/mL anti-CD40 antibody (G28.5, ATCC) and 200 IU/mL of recombinant human IL-4 (R&D Systems Ltd.)4.
RNA extraction and expression profiling. Post stimulation with IL-4 and anti-CD40, cells were 
harvested at 0, 12, 36, 72, 120 and 288 hours. RNA was extracted using the RNeasy MINI Kit (Qiagen Ltd.). 
Quantity and quality of RNA was assessed using a spectrophotometer and Bioanalyser RNA Nano Chip (Agilent 
Technologies Ltd) respectively. One μ g of high quality RNA was synthesised to double-stranded cDNA using the 
one-cycle cDNA kit (Affymetrix Ltd.) after RNA reduction to reduce 18 S RNA. In vitro transcription of cRNA 
was carried out using the IVT kit (Affymetrix Ltd.) resulting in complementary amplification and biotin label-
ling. cRNA was purified, concentrated and checked for quality and quantity. Ten μ g of cRNA was fragmented and 
Figure 5. Differential CCL17 exon retention during the activation of CSR. Relative log2-fold-changes 
between sequential time points are shown by exon for the gene CCL17 (TC 3662710). Each exon is represented 
by a solid circle the size of which is weighted by its significance. Exons that meet criteria for significant 
differential splicing at a 5% FDR are highlighted in red. Relative log2-fold-change is defined as the difference 
between the log2-fold-change for a given exon and the overall log2-fold-change for that gene. Abbreviations: 
Transcript Cluster (TC), Fold Change (FC), Time Point (TP), False Discovery Rate (FDR).
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hybridised onto a Human Exon 1.0 ST Array (Affymetrix Ltd) for 16 hours. GeneChips were washed, stained on 
a Fluidics 450 station and scanned using a high-resolution scanner (Affymetrix Ltd.).
Array data analysis. All microarray data analysis was carried out in accordance with the recommended 
best practices in the field. Data quality was assessed using Affymetrix Power Tools (APT, 1.16.1) and Array 
Quality Metrics (Version 3.22.1)70. Subsequent analyses were carried out both at the exon (probeset) and the gene 
(meta-probeset) level for the characterisation of dynamics in exon retention and global gene expression respectively.
I. Exon level analysis. Raw signal intensity data were normalised and summarized into core probesets through the 
Robust Multi-array Average (RMA) method implemented in APT. Probesets failing to achieve a significant DABG 
statistic in any sample, and probesets annotated as cross hybridising (Release 35 Affymetrix annotations) were 
removed. Following filtration 183,349 probesets, relating to 16,282 genes with > 1 exon were retained for analysis.
Evidence for variation in exon usage was sought using the Limma function diffSplice (Version 3.22.7) com-
paring log-fold changes between sequential time points for exons of the same gene, and yielding gene-wise Simes 
adjusted P-values, with the false discovery rate (FDR) controlled under 0.0525.
Patterns of functional or cellular enrichment were assessed though Gene Ontology (GO) using Database 
for Annotation, Visualization and Integrated Discovery (DAVID)(v6.7)71,72. Terms relating to molecular func-
tion (MF), biological process (BP) and cellular component (CC) were tested for enrichment in the differentially 
spliced genes relative to all genes targeted by filtered probesets. Significance was assessed using a Benjamini 
adjusted P-value to control the family-wide false discovery rate (FDR) under 0.05.
II. Gene level analysis. Raw signal intensity data were normalised and summarized into core transcript clusters 
(TCs) using the APT implementation of the RMA algorithm. TCs classified as part of the main design were 
retained. Since DABG is not suitable for analyses performed at the gene level, presence/absence was inferred 
directly from expression values, with universally low expressed TCs removed. Universal low expression was 
defined as expression less than or equal to the dataset median across all samples in the study.
Differential expression analysis was performed in Limma, blocking by sample, generating comparisons 
between each sequential time point and calculating an overall test of significance for each gene (the moderated 
F statistic). P-values were adjusted for multiple testing by the Benjamini and Hochberg method, controlling the 
expected FDR below 0.05. Patterns of enrichment for Gene Ontology terms were assessed though DAVID (v6.7) 
using the Benjamini method of P-value adjustment, relative to all genes (TC) tested for differential expression. 
Temporal clustering patterns were determined by fuzzy c-means clustering implemented in Mfuzz (2.26.0)73. 
Sub-structure within temporal profiles was assessed through hierarchical clustering using the complete linkage 
method and the Euclidean distance metric. A cut height of 4 was applied to allow differential colouring of dendro-
gram branches. Genomic co-localisation of differentially expressed genes was examined by seeking differentially 
expressed genes located within 5 Kb of one another. Cluster-specific enrichment for UCSC transcription factor 
binding sites and GO Biological Process terms was tested using DAVID and the Benjamini method of P-value 
adjustment relative to all genes (transcript clusters) tested for differential expression72,73.
Microarray data for samples used in the comparison have been deposited in ArrayExpress with Accession 
Number E-MTAB-4937.
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